These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3801768)

  • 1. The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat.
    Curtis MJ; Walker MJ
    Br J Pharmacol; 1986 Sep; 89(1):137-47. PubMed ID: 3801768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.
    Curtis MJ; MacLeod BA; Walker MJ
    Br J Pharmacol; 1984 Oct; 83(2):373-85. PubMed ID: 6487902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
    Farkas A; Qureshi A; Curtis MJ
    Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil.
    Raschack M
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):285-91. PubMed ID: 1004639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.
    Curtis MJ; Walker MJ; Yuswack T
    Br J Pharmacol; 1986 Jun; 88(2):355-61. PubMed ID: 3755364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
    Pugsley MK; Saint DA; Penz MP; Walker MJ
    Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9.
    Curtis MJ; Walker MJ
    Br J Pharmacol; 1988 Aug; 94(4):1275-86. PubMed ID: 3207985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia.
    Wolfe CL; Donnelly TJ; Sievers R; Parmley WW
    Cardiovasc Res; 1991 Feb; 25(2):101-9. PubMed ID: 1742760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accentuated negative inotropism of verapamil after ischaemic intervention in isolated working rat heart.
    Konishi T; Nakamura Y; Konishi T; Kawai C
    Cardiovasc Res; 1984 Oct; 18(10):639-44. PubMed ID: 6488233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.
    MacLeod BA; Moult M; Saint KM; Walker MJ
    Br J Pharmacol; 1989 Dec; 98(4):1165-72. PubMed ID: 2611487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the enantiomers of the dihydropyridine derivative 202-791 on contractility, coronary flow and ischemia-related arrhythmias in rat heart.
    Uematsu T; Cook NS; Hof RP; Vozeh S; Follath F
    Eur J Pharmacol; 1986 Apr; 123(3):455-8. PubMed ID: 3720830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.
    Fagbemi O; Kane KA; McDonald FM; Parratt JR; Rothaul AL
    Br J Pharmacol; 1984 Sep; 83(1):299-304. PubMed ID: 6487894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
    Curtis MJ; Garlick PB; Ridley PD
    J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (-), (+/- ), and (+) verapamil on coronary occlusion-induced mortality and infarct size.
    Au TL; Curtis MJ; Walker MJ
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):327-31. PubMed ID: 2444782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil has antiarrhythmic effects that are mediated in brain through endogenous opioids.
    Rabkin SW
    J Cardiovasc Pharmacol; 1994 May; 23(5):814-21. PubMed ID: 7521466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH changes on the actions of verapamil on cardiac excitation-contraction coupling.
    Achike FI; Dai S
    Eur J Pharmacol; 1991 Apr; 196(1):77-83. PubMed ID: 1651870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on reoxygenation and programmed electrical stimulation-induced ventricular arrhythmias in the isolated heart.
    Pahor M; Bernabei R; Gambassi G; Carbonin PU
    Int J Cardiol; 1989; 25 Suppl 1():S71-9. PubMed ID: 2620998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.